CARDIFF ONCOLOGY, INC. (CRDF) Operating margin 2016–2025
CARDIFF ONCOLOGY, INC. (CRDF) operating margin by fiscal year — reported operating income divided by reported revenue.
-8256.3%FY2025 · since FY2016: -10534.9% → -8256.3%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -8256.3% | -1133.2 pp |
| FY2024 | -7123.1% | +2182.6 pp |
| FY2023 | -9305.7% | +1031.6 pp |
| FY2022 | -10337.3% | -2299.7 pp |
| FY2021 | -8037.6% | -2822.9 pp |
| FY2020 | -5214.8% | +1603.0 pp |
| FY2019 | -6817.8% | -2310.2 pp |
| FY2018 | -4507.6% | +556.8 pp |
| FY2017 | -5064.4% | +5470.5 pp |
| FY2016 | -10534.9% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More CRDF financial trends
CRDF RevenueCRDF Net incomeCRDF Net marginCRDF Gross profitCRDF Gross marginCRDF Operating incomeCRDF Operating cash flowCRDF Free cash flowCRDF Capital expendituresCRDF Return on equityCRDF Stock buybacksCRDF Dividends paidCRDF Total assetsCRDF Total liabilitiesCRDF Shareholders’ equityCRDF overview →